{"nctId":"NCT01263483","briefTitle":"Efficacy and Safety of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan","startDateStruct":{"date":"2007-01"},"conditions":["Type 2 Diabetes Mellitus"],"count":230,"armGroups":[{"label":"Voglibose 0.2 mg TID","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Voglibose"]},{"label":"Alogliptin 12.5 mg QD and Voglibose 0.2 mg TID","type":"EXPERIMENTAL","interventionNames":["Drug: Alogliptin and voglibose"]},{"label":"Alogliptin 25 mg QD and Voglibose 0.2 mg TID","type":"EXPERIMENTAL","interventionNames":["Drug: Alogliptin and voglibose"]}],"interventions":[{"name":"Alogliptin and voglibose","otherNames":["SYR-322","BASEN®","Voglibose"]},{"name":"Alogliptin and voglibose","otherNames":["SYR-322","BASEN®","Voglibose"]},{"name":"Voglibose","otherNames":["BASEN®"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Had been receiving a stable dose and regimen of an α-glucosidase inhibitor for the last 4 weeks or longer before the start of the screening phase (Week -8) and during the screening phase.\n* Had a glycosylated hemoglobin (HbA1c) value of 6.5% or more and below 10.0% 4 weeks after the start of the screening phase (Week -4).\n* Had HbA1c differences within 10.0% at the start of the screening phase (Week -8) and 4 weeks after the start of the screening phase (Week -4) from the HbA1c value at the start of the screening phase.\n* Was receiving a specific diet therapy and an exercise therapy (if any) for the last 4 weeks or longer before the start of the screening phase (Week -8).\n\nExclusion Criteria:\n\n* Had received any antidiabetic drug other than α-glucosidase inhibitors within the last 4 weeks before the start of the screening phase (Week -8) or during the screening phase.","healthyVolunteers":false,"sex":"ALL","minimumAge":"33 Years","maximumAge":"85 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change From Baseline in Glycosylated Hemoglobin (Week 12).","description":"The change in the value of glycosylated hemoglobin (the concentration of glucose bound to hemoglobin as a percent of the absolute maximum that can be bound) collected at week 12 or final visit and glycosylated hemoglobin collected at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.04","spread":"0.457"},{"groupId":"OG001","value":"-0.96","spread":"0.553"},{"groupId":"OG002","value":"-0.91","spread":"0.485"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Glycosylated Hemoglobin (Week 2).","description":"The change in the value of glycosylated hemoglobin (the concentration of glucose bound to hemoglobin as a percent of the absolute maximum that can be bound) collected at week 2 and glycosylated hemoglobin collected at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.01","spread":"0.180"},{"groupId":"OG001","value":"-0.19","spread":"0.149"},{"groupId":"OG002","value":"-0.21","spread":"0.175"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Glycosylated Hemoglobin (Week 4).","description":"The change in the value of glycosylated hemoglobin (the concentration of glucose bound to hemoglobin as a percent of the absolute maximum that can be bound) collected at week 4 and glycosylated hemoglobin collected at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.02","spread":"0.301"},{"groupId":"OG001","value":"-0.44","spread":"0.234"},{"groupId":"OG002","value":"-0.43","spread":"0.263"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Glycosylated Hemoglobin (Week 8).","description":"The change in the value of glycosylated hemoglobin (the concentration of glucose bound to hemoglobin as a percent of the absolute maximum that can be bound) collected at week 8 and glycosylated hemoglobin collected at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.01","spread":"0.398"},{"groupId":"OG001","value":"-0.74","spread":"0.427"},{"groupId":"OG002","value":"-0.75","spread":"0.392"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Fasting Plasma Glucose (Week 2).","description":"The change between the value of fasting plasma glucose collected at week 2 and fasting plasma glucose collected at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.5","spread":"21.28"},{"groupId":"OG001","value":"-15.5","spread":"18.77"},{"groupId":"OG002","value":"-18.8","spread":"19.89"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Fasting Plasma Glucose (Week 4).","description":"The change between the value of fasting plasma glucose collected at week 4 and fasting plasma glucose collected at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.6","spread":"23.71"},{"groupId":"OG001","value":"-16.2","spread":"21.84"},{"groupId":"OG002","value":"-22.6","spread":"23.96"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Fasting Plasma Glucose (Week 8).","description":"The change between the value of fasting plasma glucose collected at week 8 and fasting plasma glucose collected at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.5","spread":"25.94"},{"groupId":"OG001","value":"-20.8","spread":"22.10"},{"groupId":"OG002","value":"-21.9","spread":"23.96"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Fasting Plasma Glucose (Week 12).","description":"The change between the value of fasting plasma glucose collected at week 12 or final visit and fasting plasma glucose collected at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-5.6","spread":"27.87"},{"groupId":"OG001","value":"-19.1","spread":"20.70"},{"groupId":"OG002","value":"-18.5","spread":"25.53"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Fasting C-peptide (Week 2).","description":"The change between the value of fasting C-peptide collected at week 2 and fasting C-peptide collected at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.03","spread":"0.668"},{"groupId":"OG001","value":"-0.07","spread":"0.593"},{"groupId":"OG002","value":"-0.01","spread":"0.599"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Fasting C-peptide (Week 4).","description":"The change between the value of fasting C-peptide collected at week 4 and fasting C-peptide collected at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.05","spread":"0.753"},{"groupId":"OG001","value":"0.06","spread":"0.955"},{"groupId":"OG002","value":"0.01","spread":"0.682"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Fasting C-peptide (Week 8).","description":"The change between the value of fasting C-peptide collected at week 8 and fasting C-peptide collected at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.07","spread":"0.691"},{"groupId":"OG001","value":"0.03","spread":"0.725"},{"groupId":"OG002","value":"-0.01","spread":"0.468"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Fasting C-peptide (Week 12).","description":"The change between the value of fasting C-peptide collected at week 12 or final visit and fasting C-peptide collected at baseline.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.02","spread":"0.664"},{"groupId":"OG001","value":"0.06","spread":"0.680"},{"groupId":"OG002","value":"0.10","spread":"0.620"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Blood Glucose Measured by Meal Tolerance Testing (2-hr Postprandial Value).","description":"The change between the value of blood glucose collected at week 12 or final visit and blood glucose collected at baseline. Meal tolerance test measures blood glucose, insulin, C-peptide and glucagon through blood samples drawn before a meal and at 2 hours after the start of the meal.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"72.4","spread":"34.89"},{"groupId":"OG001","value":"40.9","spread":"23.23"},{"groupId":"OG002","value":"38.7","spread":"32.33"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Blood Glucose Measured by Meal Tolerance Testing (AUC (0-2)).","description":"The change between the value of blood glucose collected at week 12 or final visit and blood glucose collected at baseline. Meal tolerance test measures blood glucose, insulin, C-peptide and glucagon through blood samples drawn before a meal and at 2 hours after the start of the meal.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-4.3","spread":"60.23"},{"groupId":"OG001","value":"-74.7","spread":"61.76"},{"groupId":"OG002","value":"-76.8","spread":"63.19"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Insulin Measured by Meal Tolerance Testing (AUC(0-2).","description":"The change between the value of insulin collected at week 12 or final visit and insulin collected at baseline as measured by the meal tolerance test. Meal tolerance test measures blood glucose, insulin, C-peptide and glucagon through blood samples drawn before a meal and at 2 hours after the start of the meal.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.47","spread":"10.817"},{"groupId":"OG001","value":"4.62","spread":"16.599"},{"groupId":"OG002","value":"1.50","spread":"14.845"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in C-peptide Measured by Meal Tolerance Testing (AUC(0-2).","description":"The change between the value of C-peptide collected at week 12 or final visit and C-peptide collected at baseline as measured by the meal tolerance test. Meal tolerance test measures blood glucose, insulin, C-peptide and glucagon through blood samples drawn before a meal and at 2 hours after the start of the meal.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.14","spread":"1.670"},{"groupId":"OG001","value":"0.69","spread":"1.901"},{"groupId":"OG002","value":"0.57","spread":"2.247"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Glucagon Measured by Meal Tolerance Testing (AUC (0-2)).","description":"The change between the value of glucagons collected at week 12 or final visit and glucagons collected at baseline. Meal tolerance test measures blood glucose, insulin, C-peptide and glucagon through blood samples drawn before a meal and at 2 hours after the start of the meal.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.4","spread":"64.18"},{"groupId":"OG001","value":"-19.2","spread":"42.72"},{"groupId":"OG002","value":"-20.5","spread":"41.97"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":9,"n":75},"commonTop":["Nasopharyngitis","Eczema"]}}}